PTXPRESCIENT THERAPEUTICS LIMITEDMarket sensitive

PTX-100 CTCL Phase 2a study reaches review milestone

Date and time
Announcement type
Company Update

More from Health Care

More News

VR8Company Update5 October 2026

Vanadium Resources (ASX: VR8) Maps US$842m V-Iron Case